Julina Post-marketing Surveillance for Climacteric Symptoms in Japan
Status:
Completed
Trial end date:
2014-04-15
Target enrollment:
Participant gender:
Summary
This study is a regulatory post-marketing surveillance in Japan, and it is a local
prospective and observational study of patients who have received Julina for postmenopausal
osteoporosis. The objective of this study is to assess safety and efficacy of using Julina in
clinical practice. A total 100 patients will be recruited and followed 3 years since starting
Julina administration.